Description

LETRO-M is a pharmaceutical medication containing the active ingredient Letrozole at a strength of 2.5mg per tablet. Presented in a box containing 10 tablets, this medication belongs to a class of drugs known as aromatase inhibitors. It is primarily indicated for the treatment of postmenopausal breast cancer, working by lowering estrogen levels in the body to help slow or stop the growth of specific hormone-responsive tumors. Additionally, it is used to manage other specific hormone-responsive conditions under strict medical supervision.